Sensient Technologies Corp
$6.41B- Market cap
- $5.74B
- Debt
- +$709.58M
- Cash
- −$36.53M
Capital structure 89% equity / 11% debt · EV / Revenue 3.98x · EV / EBITDA 26.86x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: SXT stock price vs PFE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PFE's multiple
Needs PFE P/E.
Implied fair value · at SXT's multiple
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SXT FY 2025 (ended Dec 31, 2025) · PFE FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 89% equity / 11% debt · EV / Revenue 3.98x · EV / EBITDA 26.86x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Sensient Technologies Corp · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
PFIZER INC · implied price per share
Bear
$10.17
Base
$12.82
Bull
$17.53
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.59x
0.75x
Net debt / EBITDA
Leverage against operating earnings
2.82x
4.93x
Cash and equivalents
Liquid reserves on the balance sheet
$36.53M
$1.14B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTERNATIONAL FLAVORS & FRAGRANCES INC
SXT vs IFF
COTY INC.
SXT vs COTY
ECOLAB INC.
SXT vs ECL
Ingredion Inc
SXT vs INGR
JOHNSON & JOHNSON
SXT vs JNJ
Merck & Co., Inc.
SXT vs MRK
AbbVie Inc.
SXT vs ABBV
BRISTOL MYERS SQUIBB CO
SXT vs BMY
ELI LILLY & Co
SXT vs LLY
AMGEN INC
SXT vs AMGN
$709.58M
$64.80B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.